Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways

Jon G Mabley1, Pál Pacher, Peter Bai

  • 1Inotek Pharmaceuticals Corporation, 100 Cummings Center, Suite 419E, Beverly, MA 01915, USA. jmabley@inotekcorp.com

Mutation Research
|April 6, 2004
PubMed

Insights

Reactive nitrogen species, particularly peroxynitrite, drive intestinal polyp development in Apc(min/+) mice. Inhibiting these species and poly(ADP-ribose) synthetase shows potential for colorectal cancer chemoprevention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Apc(min/+) mice model intestinal polyposis due to a germ-line mutation in the adenomatous polyposis coli gene.
  • Increased oxidative stress is observed in the intestinal mucosa of these mice, correlating with polyp formation.

Purpose of the Study:

  • To investigate the role of reactive nitrogen species and poly(ADP-ribose) synthetase in intestinal tumorogenesis using the Apc(min/+) mouse model.
  • To evaluate the therapeutic potential of targeting these pathways for colorectal cancer chemoprevention.

Main Methods:

  • Pharmacological inhibition of inducible nitric oxide synthase (NOS) using guanidinoethyldisulfide (GED).
  • Catalytic decomposition of peroxynitrite using FP 15.
  • Inhibition of poly(ADP-ribose) synthetase using PJ 34.
  • Assessment of intestinal tumor load and oxidative stress markers.

Main Results:

  • Inhibition of NOS and peroxynitrite decomposition significantly reduced intestinal tumor load and oxidative stress in Apc(min/+) mice.
  • Pharmacological inhibition of poly(ADP-ribose) synthetase also decreased polyposis and oxidative stress, potentially via NOS inhibition.
  • Reactive nitrogen species, especially peroxynitrite, are implicated as key drivers of intestinal polyposis.

Conclusions:

  • Reactive nitrogen species, particularly peroxynitrite, play a critical role in the development of intestinal polyps.
  • Targeting oxidative stress and reactive nitrogen species formation presents a promising chemopreventive strategy for colorectal cancers.
  • Poly(ADP-ribose) synthetase inhibition may offer a novel approach to reduce polyposis and oxidative stress in the context of Apc mutations.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...